David M. Mintzer, MD

Hematology, Medical Oncology

4.9 with 1406 ratings

Sees patients age 18 and up

David M. Mintzer, MD

Hematology, Medical Oncology

4.9 with 1406 ratings

Sees patients age 18 and up

Chief, Section of Hematology Oncology, Pennsylvania Hospital
Clinical Professor of Medicine (Hematology-Oncology)
Dr. Mintzer is a Penn Medicine physician.

Call 800-789-7366 Request Appointment

All Cancer Types

Adjuvant Chemotherapy
All Cancer Types
Anal Cancer
Anemia and Bone Marrow Disorders
Anticoagulation
Bile Duct Cancer (Cholangiocarcinoma)
Bladder Cancer
Bleeding Disorder
Blood Disorders
Blood Platelet Disorders
Bone Marrow Biopsy
Breast Cancer
Breast Cancer Immunotherapy
Cancer During Pregnancy
Cancer Immunotherapy
Cancer Pain
Cancer Survivor
Carcinoid Tumors
Carcinoma of Unknown Primary
Chemotherapy for Cancer
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)
Clinical Trials
Coagulation Disorders
Colon Cancer
Deep Vein Thrombosis
Esophageal Cancer
Essential Thrombocytosis
Factor V Leiden
Gallbladder Cancer
Gastrointestinal Cancer (GI Cancer)
Gastrointestinal Stromal Tumors (GIST)
Hairy Cell Leukemia
Hematologic Malignancies
Hemochromatosis
Hemoglobinopathies
Hemolytic Anemia
Heparin-Induced Thrombocytopenia
Hodgkin Lymphoma
Hypercoagulable State
Hypogammaglobulinemia
Idiopathic Thrombocytopenic Purpura
Inflammatory Breast Cancer (IBC)
Iron Deficiency Anemia
Kidney Cancer
Large Granular Lymphocytic Leukemia
Leukemia
Leukocytosis
Leukopenia
Light Chain Disorders
Liver Cancer
Low Platelet Count (Thrombocytopenia)
Lung Cancer
Lupus Anticoagulant
Lymphoma
Male Breast Cancer
Marginal Zone Lymphoma
Maternal Anticoagulation
Maternal Hematologic Disorders
Maternal Thrombophilia
Mediastinal Lymphoma
Melanoma
Merkel Cell Carcinoma
Mesothelioma
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mucosa-Associated Lymphoid Tissue Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPNs)
Neoadjuvant Chemotherapy
Neuroendocrine Tumor
Neutropenia
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Pancreatic Cancer
Pancytopenia
Peripheral T-Cell Lymphoma
Plasma Cell Dyscrasia
POEMS Syndrome
Polycythemia
Porphyria
Post Thrombotic Syndrome
Primary Myelofibrosis
Primary Systemic Amyloidosis
Prolymphocytic Leukemia
Prostate Cancer
Protein C Deficiency
Protein S Deficiency
Prothrombin Gene Mutation
Pure Red Cell Aplasia
Rectal Cancer
Red Blood Cell Disorders
Refractory Anemia With Excess Blasts
Secondary Polycythemia
Sickle Cell Disease
Small Cell Lung Cancer
Spinal Tumor
Splenomegaly
Stomach Cancer (Gastric Cancer)
Targeted Therapy
Testicular Cancer
Thalassemia
Thoracic Cancer
Thrombocytosis
Thrombophilia
Thrombotic Disorders
Thrombotic Thrombocytopenic Purpura
Transitional Cell Carcinoma
Ureteral Cancer
Urethral Cancer
Von Willebrand Disease
Waldenstrom Macroglobulinemia (WM)
White Blood Cell Disorders

Show All Expertise

Programs and Centers

Penn Medicine's programs and centers combine doctors from many disciplines to coordinate care from start to finish. Dr. Mintzer is part of these programs:

Board Certification

Hematology, 1982
Internal Medicine, 1980
Medical Oncology, 1983

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital; Memorial Sloan-Kettering Cancer Center

Primary Location

Penn Hematology/Oncology Pennsylvania Hospital

Pennsylvania Hospital
Abramson Cancer Center, Farm Journal Building, 2nd Floor
719 Manning St.
Philadelphia, PA 19106

Map Call 800-789-7366

View details

Abramson Cancer Center Radnor

Penn Medicine Radnor
Floor 2, Suite 200 North
145 King of Prussia Road
Radnor, PA 19087

A facility of the Hospital of the University of Pennsylvania

Map Call 610-902-5950

View details

Penn Medicine Hospital Privileges

Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Overall Ratings

out of 5 ; Ratings;

The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Responses are measured on a scale of 1 to 5 with 5 being the best score. Scores reflect either the most recent 12 months of surveys or the most recent 30 surveys overall. Data is updated monthly and comments remain on the profile for 12 months.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Patients that are treated in outpatient or hospital environments may receive different surveys.

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Aetna
Amerihealth Caritas (Transplant patients only)
Centivo
Cigna Healthcare
Cigna Healthcare
Claim Watcher (Homestead/Index)
Clover Health
Devoted Health Plan
Geisinger Health Plan
Geisinger Health Plan
Global Medical Management
HealthAmerica / HealthAssurance, a Coventry Plan
Highmark Blue Shield
Highmark Blue Shield
Highmark Wholecare (fka Gateway Health)
Horizon BC/BS of NJ
Humana Medicare
Humana Military (Tricare/Health Net Federal Services)
Imagine Health (Imagine Health 360)
Independence Blue Cross (IBC)

Jefferson Health Plans/Health Partners
Jefferson Health Plans/Health Partners (Includes CHIP)
Keystone First Health Plan
Keystone First Health Plan
Medicaid - New Jersey
Medicaid - Pennsylvania
Medicare - Pennsylvania
Oscar Health Plan of PA
Oxford Health Plan
PA Health & Wellness
Perennial Advantage
Preferred Health Care/Eliance
Provider Partners Health Plan
Qualcare
Rail Road Medicare/Palmetto GBA
UnitedHealthcare
UnitedHealthcare Community Plan of PA
UPMC Health Plan
US Family Health Plan
VA Insurance (Veteran's CCN)

Selected Publications

David M. Mintzer: But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care Journal of Clinical Oncology 41 (26): 4313,2023.

Mintzer D, Henry D: FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies MDEdge : 2021.

Mintzer D, Henry D: FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs MDEdge : 2021.

David Mintzer: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship American College of Physicians : 2021.

Deye, DL; Mintzer D: MKSAP 19 Audio companion Oakstone : 2021.

Mintzer D: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship American College of Physicians : 2021.

Bryer E, Mintzer D, Henry DH: 2019 At a Glance: Hem-Onc U.S. Drug Approvals MDedge/Hematology and Oncology : 2019.

Emily Bryer, Monique Neault, David Mintzer: Managing Dying: Medical Care and Decision Making at the Very End-of-Life Palliative Medicine & Care: Open Access : DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180,2019.

Bryer E, Mintzer D, Henry D: 2018 At A Glance: Recently Approved Therapies in Oncology MD Edge/Hematology and Oncology : ://mdedge-files-live.s3.us-east-2.amazonaws.com,2019.

Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC: Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Leukemia and Lymphoma : 1-4,2019.

Academic Contact Information

Pennsylvania Hospital
Abramson Cancer Center at Pennsylvania Hospital
Farm Journal Building
230 West Washington Square, 2nd Floor
Philadelphia, PA 19106
Phone: 215-829-7704
Patient appointments: 800-789-7366

American College of Physicians, National
American Society of Clinical Oncology, National
American Society of Hematology, National